Vascepa — Medica
Cardiovascular risk reduction in a patient with elevated triglycerides
Initial criteria
- Patient has established cardiovascular disease OR (Patient has diabetes AND patient has at least two additional risk factors for cardiovascular disease)
- Fasting baseline triglyceride level ≥ 150 mg/dL prior to initiation of therapy
- Patient is receiving statin therapy OR cannot tolerate statin therapy
Approval duration
1 year